APH vs COCP · P/E 40, rev $23.09B vs rev $105.0K
Amphenol Corporation (APH) versus Cocrystal Pharma Inc (COCP) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. COCP currently screens at market cap $13.3M.
Not investment advice. Open the APH and COCP stock pages for the full models.
Not investment advice.